ZIM Laboratories Limited (ZIMLAB.NS)
INR 112.56
(0.39%)
INR 112.56
(0.39%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 356 Million INR | 44.57% |
| 2022 | 246.24 Million INR | 25.34% |
| 2021 | 196.45 Million INR | -10.69% |
| 2020 | 219.96 Million INR | -21.57% |
| 2019 | 280.46 Million INR | 26.56% |
| 2018 | 221.6 Million INR | 9.25% |
| 2017 | 202.83 Million INR | -27.27% |
| 2016 | 278.87 Million INR | -19.75% |
| 2015 | 347.51 Million INR | -7.55% |
| 2014 | 375.87 Million INR | -5.26% |
| 2013 | 396.76 Million INR | 114.6% |
| 2012 | 184.88 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 356 Million INR | 44.57% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 356 Million INR | 0.0% |
| 2023 Q2 | 378.73 Million INR | 0.0% |
| 2022 FY | 246.24 Million INR | 25.34% |
| 2022 Q4 | 246.24 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 219.71 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 196.45 Million INR | -10.69% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 178.58 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 196.45 Million INR | 0.0% |
| 2020 Q2 | 234.71 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 219.96 Million INR | 0.0% |
| 2020 FY | 219.96 Million INR | -21.57% |
| 2019 FY | 280.46 Million INR | 26.56% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 332.98 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 280.46 Million INR | 0.0% |
| 2018 Q4 | 221.6 Million INR | 0.0% |
| 2018 FY | 221.6 Million INR | 9.25% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 244.77 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q4 | 202.83 Million INR | 0.0% |
| 2017 FY | 202.83 Million INR | -27.27% |
| 2016 FY | 278.87 Million INR | -19.75% |
| 2015 FY | 347.51 Million INR | -7.55% |
| 2014 FY | 375.87 Million INR | -5.26% |
| 2013 FY | 396.76 Million INR | 114.6% |
| 2012 FY | 184.88 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 265.79 Million INR | -33.939% |
| Ind-Swift Limited | 10.09 Billion INR | 96.473% |
| Bajaj HealthCare Limited | 650.34 Million INR | 45.259% |
| Sakar Healthcare Limited | 549.55 Million INR | 35.219% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.332% |
| Innova Captab Limited | 2.1 Billion INR | 83.089% |
| Divi's Laboratories Limited | 20 Million INR | -1680.03% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1178.941% |
| Morepen Laboratories Limited | 33.64 Million INR | -958.282% |
| Mankind Pharma Limited | 325.81 Million INR | -9.266% |
| Sequent Scientific Limited | 1.42 Billion INR | 75.055% |
| Wanbury Limited | 820 Million INR | 56.585% |
| Laurus Labs Limited | 7.98 Billion INR | 95.54% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 74.627% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -141.18% |
| Alembic Limited | 73.9 Million INR | -381.74% |
| Hikal Limited | 4.22 Billion INR | 91.581% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 43.383% |
| Neuland Laboratories Limited | 449.2 Million INR | 20.748% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -50.595% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 76.531% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Themis Medicare Limited | 267.74 Million INR | -32.967% |
| RPG Life Sciences Limited | -30.3 Million INR | 1274.937% |
| Zydus Lifesciences Limited | 251 Million INR | -41.835% |
| Lupin Limited | 1.55 Billion INR | 77.073% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -2448.726% |
| Wockhardt Limited | 8.91 Billion INR | 96.004% |
| Vaishali Pharma Limited | 35.98 Million INR | -889.373% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -88901.5% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -371.094% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 98.876% |
| FDC Limited | 2.46 Million INR | -14336.577% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 94.057% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 94.561% |
| Venus Remedies Limited | 386.8 Million INR | 7.961% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -0.024% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -3769.63% |
| Shilpa Medicare Limited | 5.6 Billion INR | 93.645% |
| Albert David Limited | 6.01 Million INR | -5817.653% |
| Ajanta Pharma Limited | 235.2 Million INR | -51.363% |
| Hester Biosciences Limited | 1.81 Billion INR | 80.415% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -67.646% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 69.686% |
| Gufic Biosciences Limited | 1.53 Billion INR | 76.877% |
| Windlas Biotech Limited | 20.18 Million INR | -1664.153% |
| Procter & Gamble Health Limited | 68.8 Million INR | -417.451% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -1004.108% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -166.589% |
| Granules India Limited | 689.71 Million INR | 48.383% |
| Aarti Drugs Limited | 2.75 Billion INR | 87.07% |
| Bal Pharma Limited | 363.82 Million INR | 2.149% |
| Alkem Laboratories Limited | 400 Million INR | 10.999% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -2576.737% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -2735.571% |
| Unichem Laboratories Limited | 382.22 Million INR | 6.859% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -231.07% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Valiant Laboratories Limited | 750.89 Million INR | 52.589% |
| Orchid Pharma Limited | 1.2 Billion INR | 70.439% |
| Medico Remedies Limited | 8.67 Million INR | -4005.235% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -218.927% |
| Ipca Laboratories Limited | 5.8 Billion INR | 93.866% |
| Brooks Laboratories Limited | 3.56 Million INR | -9886.143% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 29304.758% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.934% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 97.781% |
| NATCO Pharma Limited | 53 Million INR | -571.709% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 80.599% |
| Strides Pharma Science Limited | 6.71 Billion INR | 94.698% |
| Indoco Remedies Limited | 3.51 Billion INR | 89.878% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -233.964% |